Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors: A Randomized Controlled Trial
McGill University
50 participants
Jan 15, 2022
INTERVENTIONAL
Conditions
Summary
This randomized control trial seeks to determine whether a tailored and supervised exercise program adopting mobile-health technology will be able to improve fitness and quality of life among lymphoma survivors.
Eligibility
Inclusion Criteria5
- newly diagnosed lymphoma patients who received an initial diagnosis at the age of age 18-39,
- approved by their hematologist as having no contra-indications to vigorous exercise,
- receiving or has received chemotherapy with curative intent within the past 6 months,
- own a cellular phone that is able to download the Fitbit app and to complete the study questionnaires online in either French or English, and
- has an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom).
Exclusion Criteria2
- The patient has contra-indications to vigorous exercise,
- the patient doesn't want to wear a fitness tracker due to various concerns (as no Fitbit data could be collected).
Interventions
Participants randomized to this arm will be allocated a pre-registered Inspire II / Charge IV model Fitbit. The kinesiologist of the study will meet with the participants for a baseline fitness assessment. The kinesiologist will examine the baseline physical activity levels, fitness level and sedentary behaviours of the participants, to design a personalized exercise prescription. Within one week after the baseline fitness assessment, the kinesiologist will contact the participants to discuss the exercise prescription. Every two weeks there-after, the kinesiologist will follow up with the participants via videoconferencing to discuss their progress and to modify or advance their exercise prescriptions as needed. Participants will be followed-up at 6 months and 12 months.
Participants will be contacted by the study kinesiologist for a baseline fitness assessment 3 months after they consent, participants will be given a Fitbit, a personalized exercise prescription and receive bi-weekly follow-ups for 12 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05257785